CETP inhibitors and cardiovascular disease: Time to think again [v1; ref status: indexed, http://f1000r.es/3mp]
Inhibition of cholesteryl ester transfer protein (CETP) lowers plasma low-density lipoprotein cholesterol concentration and raises high-density lipoprotein (HDL) cholesterol, suggesting it might prevent cardiovascular disease (CVD). From the outset, however, the concept has been controversial owing...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2014-06-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | http://f1000research.com/articles/3-124/v1 |